Background: Current clinical practice still lacks consistent evidence in the physiotherapy management of Rotator cuff related pain syndrome (RCS). The purpose of this trial was to compare the effectiveness of a scapular-focused treatment with and without real-time electromyographic biofeedback (EMGBF) to a control therapy in patients with RCS. Methods: 60 patients with RCS were divided into three groups: scapular-focused exercise protocol group (P\_G n=20), scapular-focused exercise protocol with EMGBF group (P+EMGBF\_G n=20) and control therapy group (CT\_G n=20). Values of pain and function \[Shoulder Pain and Disability Index (SPADI) questionnaire, complemented by the Numeric Pain Rating Scale (NPRS) and Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire\], scapular stabilizer neuromuscular control (SSNC), scapular stabilizer activation onset (SSAO), dynamic scapular alignment, range of motion (ROM) and glenohumeral flexor and abductor muscle strength (GMS) were assessed at baseline and after 6-weeks and compared within and between groups.
In order to advance the understanding of the value of scapular-focused exercise for rotator cuff related syndrome, a new trial was designed with the main objective of comparing pain and function outcomes between three different treatment protocols for patients with RCS: P\_G - Scapular-focused exercise protocol without electromyographic biofeedback (EMGBF) P+EMGBF\_G - Scapular-focused exercise protocol supported by real-time EMGBF CT\_G - Control therapy group with manual therapy (glenohumeral joint physiologic and accessory mobilization) , massage to reduce upper trapezius (UT) stiffness, and shoulder rotation strengthening into external rotation Every outcomes was assessed at the beginning of treatment, and then, weekly until completed 6 weeks of treatment.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
60
Scapular-focused exercises, based on the dos Santos et al (2021) protocol with the aid of the electromyographic biofeedback
manual and exercise therapy
Scapular-focused exercises, based on the dos Santos et al (2021) protocol
Policlínica de Sátão
Viseu, Portugal
NPRS numeric pain rating scale
From zero (better score) to 10 (worst score)
Time frame: At the initial assessment
NPRS numeric pain rating scale
From zero (better score) to 10 (worst score)
Time frame: At 6 weeks after the treatment protocol (final assessment)
SPADI shoulder pain and disability index
From zero (better score) to 100 (worst score)
Time frame: At the initial assessment
SPADI shoulder pain and disability index
From zero (better score) to 100 (worst score)
Time frame: At 6 weeks after the treatment protocol (final assessment)
DASH disabilities of the arm, shoulder and hand
From zero (better score) to 100 (worst score)
Time frame: At the initial assessment
DASH disabilities of the arm, shoulder and hand
From zero (better score) to 100 (worst score)
Time frame: At 6 weeks after the treatment protocol (final assessment)
scapular stabilizer neuromuscular control
Electromyographic Biofeedback (EMGBF) PhysiopluxTM system version 1.06
Time frame: At the initial assessment
scapular stabilizer neuromuscular control
Electromyographic Biofeedback (EMGBF) PhysiopluxTM system version 1.06
Time frame: At 6 weeks after the treatment protocol (final assessment)
scapular stabilizer activation onset
Electromyographic Biofeedback (EMGBF) PhysiopluxTM system version 1.06
Time frame: At the initial assessment
scapular stabilizer activation onset
Electromyographic Biofeedback (EMGBF) PhysiopluxTM system version 1.06
Time frame: At 6 weeks after the treatment protocol (final assessment)
dynamic scapular alignment
Observation of the medial and the inferior prominences of the scapula
Time frame: At the initial assessment
dynamic scapular alignment
Observation of the medial and the inferior prominences of the scapula
Time frame: At 6 weeks after the treatment protocol (final assessment)
range of motion
Goniometry
Time frame: At the initial assessment
range of motion
Goniometry
Time frame: At 6 weeks after the treatment protocol (final assessment)
glenohumeral flexor and abductor muscle strength
Manual Testing From 0 (worst) to 5 (normal)
Time frame: At the initial assessment
glenohumeral flexor and abductor muscle strength
Manual Testing From 0 (worst) to 5 (normal)
Time frame: At 6 weeks after the treatment protocol (final assessment)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.